Journal of Neuroimmunology
Volume 201 , Pages 13-20 , 15 September 2008

How myasthenia gravis alters the safety factor for neuromuscular transmission

  • Robert L. Ruff

      Affiliations

    • Neurology Service, Louis Stokes Department of Veterans Affairs Medical Center, Departments of Neurology and Neurosciences, Case Western Reserve University School of Medicine, Cleveland, OH, United States
    • Corresponding Author InformationCorresponding author. Chief, Neurology Service 127(W), Cleveland VAMC, 10701 East Blvd., Cleveland, OH 44106, United States. Tel.: +1 216 791 3800x5230; fax: +1 216 707 6401.
    • ,
  • Vanda A. Lennon

      Affiliations

    • Departments of Immunology, Neurology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, United States

Received 23 March 2008 ,Accepted 21 April 2008.

References 

  1. Aldrich RW, Stevens CF. Inactivation of open and closed sodium channels determined separately. Cold Spring Harbor Symp. Quant. Biol. 1983;48:147–153
  2. Aldrich RW, Stevens CF. Voltage- dependent gating of single sodium channels from mammalian neuroblastoma cells. J. Neurosci. 1987;7:418–431
  3. Aldrich RW, Corey DP, Stevens CF. A reinterpretation of mammalian sodium channel gating based on single channel recording. Nature. 1983;306:436–441
  4. Angelides KJ. Fluorescently labeled Na+ channels are localized and immobilized to synapses of innervated muscle fibres. Nature. 1986;321:63–66
  5. Caldwell JH, Campbell DT, Beam KG. Sodium channel distribution in vertebrate skeletal muscle. J. Gen. Physiol. 1986;87:907–932
  6. Casadei JM, Gordon RD, Lampson LA, Schotland DL, Barchi RL. Monoclonal antibodies against the voltage- ensitive Na+ channel from mammalian skeletal muscle. Proc. Natl. Acad. Sci. U. S. A. 1984;81:6227–6231
  7. Cohen SA, Barchi RL. Localization of epitopes for antibodies that differentially label sodium channels in skeletal muscle surface and T- tubular membranes. J. Membr. Biol. 1992;128:219–226
  8. Colquhoun D, Sigworth FJ. Fitting and statistical analysis of single-channel records. In:  Sakmann B,  Neher E editor. Single-Channel Recording. New York: Plenum Press; 1983;p. 191–263
  9. Drachman DB. Myasthenia gravis. New Engl. J. Med. 1994;330:1797–1810
  10. Engel AG. Acquired autoimmune myasthenia gravis. In:  Engel AG,  Franzini- Armstrong C editor. Myology. New York: McGraw- Hill; 1994;p. 1769–1797
  11. Engel AG, Santa T. Histometric analysis of the ultrastructure of the neuromuscular junction in myasthenia gravis and the myasthenic syndrome. Ann. N.Y. Acad. Sci. 1971;183:46–63
  12. Engel AG, Fumagalli G. Mechanisms of acetylcholine receptor loss from the neuromuscular junction. Ciba Found. Symp. 1982;90:197–224
  13. Engel AG, Lindstrom JM, Lambert EH, Lennon VA. Ultrastructural localization of the acetylcholine receptors in myasthenia gravis and in its experimental autoimmune model. Neurology. 1977;27:307–315
  14. Ermilov LG, Mantilla CB, Rowley KL, Sieck GC. Safety factor for neuromuscular transmission at type- identified diaphragm fibers. Muscle Nerve. 2007;35:800–803
  15. Fambrough DM, Drachman DB, Satyamurti S. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors. Science. 1973;182:293–295
  16. Flucher BE, Daniels MP. Distribution of Na+ channels and ankyrin in neuromuscular junctions is complementary to that of acetylcholine receptors and the 43 kD protein. Neuron. 1989;3:163–175
  17. Haimovich B, Schotland DL, Fieles WE, Barchi RL. Localization of sodium channel subtypes in rat skeletal muscle using channel- pecific monoclonal antibodies. J. Neurosci. 1987;7:2957–2966
  18. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ. Improved patch- lamp technique for high resolution current recording from cells and cell- free membrane patches. Pflügers Arch. 1981;391:85–199
  19. Horn R. Estimating the number of channels in patch recordings. Biophys. J. 1991;60:433–439
  20. Kaminski HJ, Ruff RL. The myasthenic syndromes. In:  Schultz SG,  Andreoli TE,  Brown AM,  Fambrough D,  Hoffman JF,  Welsh M editor. Physiology of Membrane Disorders Vol. 1. New York: Plenum Press; 1996;p. 565–593
  21. Kaminski HJ, Ruff RL. Structure and kinetic properties of the acetylcholine receptor. In:  Engel AG editors. Myasthenia Gravis and Myasthenic Syndromes. Contemporary Neurology Series. vol. 56:New York: Oxford University Press; 1999;p. 40–64
  22. Kao I, Drachman D. Myasthenic immunoglobulin accelerates acetylcholine receptor degradation. Science. 1977;196:526–528
  23. Kirk RE. Experimental Design: Procedures for the Behavioral Sciences. Belmont, CA: Cole Publishing Co.; 1968;
  24. Kunze DL, Lacerda AE, Wilson DL, Brown AM. Cardiac Na currents and the inactivating reopening and waiting properties of single cardiac sodium channels. J. Gen. Physiol. 1985;86:691–719
  25. Le Teut T, Boudier J- L, Jover E, Cau P. Localization of voltage- sensitive sodium channels on the extrasynaptic membrane surface of mouse skeletal muscle by autoradiography of scorpion toxin binding sites. J. Neurocytol. 1990;19:408–420
  26. Lennon VA, Lambert EH. Myasthenia gravis induced by monoclonal antibodies to acetylcholine receptors. Nature. 1980;285:238–240
  27. Lennon VA, Seybold ME, Lindstrom JM, Cochrane C, Ulevitch R. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis. J. Exp. Med. 1978;147:973–983
  28. Lindstrom JM, Einarson BL, Lennon VA, Seybold ME. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and anti-receptor complexes from muscle of rats with experimental autoimmune myasthenia gravis. J. Exp. Med. 1976;144:726–738
  29. Lindstrom JM, Engel AG, Seybold ME, Lennon VA, Lambert EH. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies. J. Exp. Med. 1976;144:739–753
  30. Martin AR. Amplification of neuromuscular transmission by postjunctional folds. Proc. Roy. Soc. B. 1994;258:321–326
  31. Maselli RA, Richman DP, Wollmann RL. Inflammation at the neuromuscular junction in myasthenia gravis. Neurology. 1991;41:1497–1504
  32. Milliken GA, Johnson DE. Designed experiments. In: Analysis of Messy Data. Vol. 1. London: Lifetime Learning Publications; 1984;p. 31–33
  33. Milton RL, Lupa MT, Caldwell JH. Fast and slow twitch skeletal muscle fibres differ in their distributions of Na channels near the endplate. Neurosci. Lett. 1992;135:41–44
  34. Ruff RL. Na current density at and away from end plates on rat fast-and slow-witch skeletal muscle fibers. Am. J. Physiol. 1992;262:C229–C234(Cell Physiol. 31)
  35. Ruff RL. Effects of length changes on Na+ current amplitude and excitability near and far from the end-late. Muscle Nerve. 1996;19:1084–1092
  36. Ruff RL. The single channel basis of slow inactivation of Na+ channels in rat skeletal muscle. Am. J. Physiol. 1996;271:C971–C981(Cell Physiol. 40)
  37. Ruff RL. Sodium channel slow inactivation and the distribution of sodium channels on skeletal muscle fibres enable the performance properties of different skeletal muscle fibre types. Acta Physiol. Scand. 1996;156:159–168
  38. Ruff RL, Lennon VA. Endplate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis. Ann. Neurol. 1998;43:370–379
  39. Ruff RL, Whittlesey D. Na+ current densities and voltage dependence in human intercostal muscle fibres. J. Physiol. (Lond.). 1992;458:85–97
  40. Ruff RL, Whittlesey D. Comparison of Na+ currents from type IIa and IIb human intercostal muscle fibers. Am. J. Physiol. 1993;265:C171–C177(Cell Physiol. 34)
  41. Ruff RL, Whittlesey D. Na+ currents near and away from endplates on human fast and slow twitch muscle fibers. Muscle Nerve. 1993;16:922–929
  42. Ruff RL, Martyn D, Gordon AL. Glucocorticoid-induced atrophy is not due to impaired excitability in rat muscle. Am. J. Physiol. 1982;243:E512–E521(Endocrinol. Metab. 6)
  43. Ruff RL, Simoncini L, Stühmer W. Comparison between slow sodium channel inactivation in rat slow and fast twitch muscle. J. Physiol. (Lond.). 1987;383:339–348
  44. Ruff RL, Simoncini L, Stühmer W. Slow sodium channel inactivation in mammalian muscle: a possible role in regulating excitability. Muscle Nerve. 1988;11:502–510
  45. Santa T, Engel AG, Lambert EH. Histometric study of neuromuscular junction ultrastructure. I. Myasthenia gravis. Neurology. 1972;22:71–82
  46. Slater CR. Structural factors influencing the efficacy of neuromuscular transmission. Ann. N.Y. Acad. Sci. 2008;1132:1–12
  47. Vincent A, McConville J, Farrugia MA, Bowen J, Plested P, Tang T, et al. Autoantibodies in myasthenia gravis and related disorders. Ann. N.Y. Acad. Sci. 2003;998:324–335
  48. Wendt DJ, Satrmer CF, Grant AO. Na+ channel kinetics remain stable during perforated-patch recordings. Am. J. Physiol. 1992;263:C1234–C1240(Cell Physiol. 32)
  49. Wood SJ, Slater CR. Action potential generation in rat slow-and fast-twitch muscles. J. Physiol. 1995;486:401–410
  50. Wood SJ, Slater CR. The contribution of postsynaptic folds to the safety factor for neuromuscular transmission in rat fast- and slow-twitch muscles. J. Physiol. 1997;500:165–176

PII: S0165-5728(08)00200-2

doi: 10.1016/j.jneuroim.2008.04.038

Journal of Neuroimmunology
Volume 201 , Pages 13-20 , 15 September 2008

Article Tools

* Image Usage & Resolution